CA
NZ
UK
AU
IND
US
BrightSpring Health Services (NASDAQ:BTSG) rose to around $60 after BMO Capital reaffirmed its bullish stance, bucking a weak day for health care stocks. Shares climbed on Friday, October 2, after BMO Capital Markets analyst Sean Dodge reiterated an Outperform rating and a $70 price …
ImmunityBio (NASDAQ:IBRX) soared on Friday, trading at about $10.28, in a sharp move that left traders searching for a reason. So far, there is none. No company-specific news was found to explain the gain. A jump that abrupt usually points to some specific piece …
Johnson & Johnson (NYSE:JNJ) shares edged lower on Friday, October 2, as the market's mood shifted from caution to risk-taking and defensive health-care names fell out of favour. No company-specific news was found for Johnson & Johnson. The drug and medical-device maker, often viewed …
Moderna (NASDAQ:MRNA) is in the spotlight afterNasdaqannounced that theVaccineand biotech company will join the Nasdaq-100 index, effective October 9, 2026, replacing Warner Bros. Discovery. The announcement capped a remarkable run for Moderna. Its stock has more than tripled since mid-August, driven by data from …
The group includes clinical-stage developers, a quantum hardware company and a manufacturer hit by aFacilitydisruption. The positive news centered on early-stage oncology survival signals, a cardiovascular biomarker readout and an upcoming interim readout in babesiosis. The negative news centered on a terminated program and …
The updates fall into three broad types. Some companies reported hard clinical or regulatory progress, some announced commercial or technology milestones, and some disclosed financing moves that affect cash runway and share count.
Boston Scientific (NYSE:BSX) slipped on Friday, ending among the S&P 500's weaker stocks on a day when health care was the only sector in theindexto fall. The Massachusetts-based company makes medical devices used in minimally invasive procedures, including heart rhythm treatments, stents, devices for …
Cardinal Health (NYSE:CAH) fell on Friday, ranking among the weakest stocks in the S&P 500 a day after it rallied on news that it had locked in a major customer for years to come. The Ohio-based company is one of America's three big pharmaceutical …
Cencora (NYSE:COR) slipped on Friday, landing among the S&P 500's weaker stocks on a day when health care was the only one of 11 sectors to close lower. The drug wholesaler, formerly known as AmerisourceBergen, distributes branded and generic medicines to pharmacies, hospitals and …
Alnylam Pharmaceuticals (NASDAQ:ALNY) slipped on Friday, finishing among the weaker stocks on the Nasdaq-100 even as the index closed at a record high. Alnylam is a pioneer of RNA interference, a type of medicine that silences disease-causing genes, with approved drugs for rare and …
Please wait processing your request...